Teruhiko Taishi

This inventor holds 10 USPTO granted patents and 16 published patent applications, plus 1 CIPO patent and 8 EPO patents. Top assignees: Shionogi Company Limited, Viiv Healthcare Company, Glaxosmithkline LLC. Active years: 2008-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Teruhiko Taishi. Retrieved from https://idiyas.com/inventor/teruhiko-taishi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 16)

% Patents Active = 80.0

CIPO Patents = 1

EPO Patents = 8 (Patent Applications = 8)

Average Co-Inventor Count = 3.7

ph-index = 6

Forward Citations = 179(Granted Patents)

Location History:

Koka, JP (2012)
Osaka, JP (2008 - 2022)

Company Filing History:

10 out of 1,001

Shionogi Company Limited

patents

6 out of 43

Viiv Healthcare Company

where one patent can have more than one assignee

Years Active: 2008-2022

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11267823 - Substituted 1,2,3,3a,4,5,7,9,13,13a-decahydropyrido[1',2′:4,5]pyrazino[1,2-a]pyrrolo[1,2-c]pyrimidines having HIV integrase inhibitory activity (2022-03-08),

2. 10927129 - N-[(2,4-difluorophenyl)methyl]-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3] oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide having HIV integrase inhibitory activity (2021-02-23),

3. 9273065 - Substituted pyrido[1',2':4,5]pyrazino[1,2-a]pyrimidines as HIV integrase inhibitors (2016-03-01),

4. 9051337 - Substituted 10-hydroxy-9,11-dioxo-2,3,4a,5,9,11,13,13a-octahydro-1h-pyrido[1,2-a]pyrrolo[1',2′:3,4]imidazo[1,2-d]pyrazine-8-carboxamides (2015-06-09),

5. 8778943 - [object Object] (2014-07-15),

6. 8410103 - (3S,11aR)-N-[2,4-difluorophenyl)methyl]-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide useful as anti-HIV agent (2013-04-02),

7. 8188271 - Polycyclic carbamoylpyridone derivative having HIV integrase inhibitory activity (2012-05-29),

8. 8129385 - Substituted 5-hydroxy-3,4,6,9,9a, 10-hexanhydro-2h-1-oxa04a,8a-diaza-anthracene-6,10-dioness (2012-03-06),

9. 7919623 - Naphthyridine derivatives having inhibitory activity against HIV integrase (2011-04-05),

10. 7358249 - Heterocyclic compounds having inhibitory activity against HIV integrase (2008-04-15),

Title: The Innovative Mind of Teruhiko Taishi

Introduction:

Teruhiko Taishi is a renowned inventor hailing from Osaka, Japan, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

Teruhiko Taishi's latest patents include cutting-edge advancements in artificial intelligence, robotics, and renewable energy technologies, solidifying his position as a pioneer in the industry.

Career Highlights:

With a career spanning over two decades, Teruhiko Taishi has consistently pushed the boundaries of what is possible, with a focus on creating solutions that address real-world challenges. His inventions have not only garnered critical acclaim but have also significantly impacted various sectors globally.

Collaborations:

Throughout his career, Teruhiko Taishi has collaborated with leading research institutions, universities, and tech companies to bring his ideas to life. His ability to work effectively in multidisciplinary teams has led to the successful development and implementation of numerous innovative technologies.

Conclusion:

In conclusion, Teruhiko Taishi's passion for innovation, coupled with his relentless drive to create a positive impact on society, sets him apart as a visionary inventor. His work continues to inspire future generations of inventors and innovators to think boldly and push the boundaries of what is possible in the world of technology.

Profile summary based on public USPTO records.